Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02640729 · ClinicalTrials.gov registry record · Phase 2

Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body Dementia

A Phase 2 study of Lewy Body Dementia and Visual Hallucinations, sponsored by Axovant Sciences.

Completed
Registry status
Phase 2
Development phase
30
Enrollment target
10
Study locations

NCT02640729 is a Phase 2 study of Lewy Body Dementia and Visual Hallucinations that has completed, run by Axovant Sciences. The registered enrollment target is 30 participants, below the 485-participant average among 8 other Lewy Body Dementia trials with a reported enrollment target (94% lower). The trial reports 10 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02640729, a Phase 2 study of Lewy Body Dementia and Visual Hallucinations, has completed, sponsored by Axovant Sciences.

COMPLETED
Registry status
Phase 2
Development phase
30 participants
Enrollment target
10
Study locations

Study Summary

This study seeks to evaluate safety and efficacy of Nelotanserin for the treatment of visual hallucinations in subjects with Lewy body dementia.

Conditions Studied

Lewy Body Dementia Visual Hallucinations

Interventions

  • DRUG Placebo
  • DRUG Nelotanserin

Study Locations (10)

Florida

  • US114 - Boca Raton
  • US113 - Orlando

Ohio

  • US104 - Cleveland
  • US105 - Columbus

California

  • US123 - Fountain Valley

Kansas

  • US132 - Lenexa

Minnesota

  • US103 - Rochester

Nebraska

  • US129 - Lincoln

North Carolina

  • US101 - Chapel Hill

Texas

  • US131 - San Antonio

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2015-12
Est. Completion 2017-11
Phase Phase 2

Sponsor

Axovant Sciences

8 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02640729

The ClinicalTrials.gov registry entry for NCT02640729 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 485-participant average among 8 other Lewy Body Dementia trials with a reported enrollment target (94% lower). The listed sponsor is Axovant Sciences, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Lewy Body Dementia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT02640729 reports 10 study locations spanning 8 distinct geographic areas - top geographies include Florida, Ohio, California.

Frequently Asked Questions

What is clinical trial NCT02640729 about?

NCT02640729 is a clinical study titled "Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body Dementia". This study seeks to evaluate safety and efficacy of Nelotanserin for the treatment of visual hallucinations in subjects with Lewy body dementia.

What is the current status of trial NCT02640729?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2015-12. Estimated completion is 2017-11.

What conditions does trial NCT02640729 study?

This clinical trial studies the following conditions: Lewy Body Dementia, Visual Hallucinations.

What interventions are being tested in trial NCT02640729?

The interventions under investigation include: Placebo (DRUG), Nelotanserin (DRUG).

Who is sponsoring clinical trial NCT02640729?

This trial is sponsored by Axovant Sciences, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02640729 being conducted?

This trial has 10 study locations across California, Florida, Kansas, Minnesota, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lewy Body Dementia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lewy Body Dementia

All registered trials for this condition

Visual Hallucinations

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.